[Federal Register Volume 82, Number 157 (Wednesday, August 16, 2017)]
[Notices]
[Pages 38912-38913]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17322]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting is scheduled to be held for the Presidential Advisory 
Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). 
The meeting will be open to the public; a public comment session will 
be held during the meeting. Pre-registration is required for members of 
the public who wish to attend the meeting and who wish to participate 
in the public comment session. Individuals who wish to attend the 
meeting and/or send in their public comment via email should send an 
email to [email protected]. Registration information is available on the Web 
site http://www.hhs.gov/ash/carb/ and must be completed by September 5, 
2017; all in-person attendees must pre-register by this date. 
Additional information about registering for the meeting and providing 
public comment can be obtained at http://www.hhs.gov/ash/carb/ on the 
Meetings page.

DATES: The meeting is scheduled to be held on September 13, 2017, from 
9:00 a.m. to 5:00 p.m. ET, and September 14, 2017, from 9:00 a.m. to 
3:00 p.m. ET (times are tentative and subject to change). The confirmed 
times and agenda items for the meeting will be posted on the Web site 
for the Advisory Council at http://www.hhs.gov/ash/carb/ when this 
information becomes available. Pre-registration for attending the 
meeting in person is required to be completed no later than September 
5, 2017; public attendance at the meeting is limited to the available 
space.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Great Hall, 200 Independence Avenue SW., Washington, 
DC 20201.
    The meeting can also be accessed through a live webcast on the day 
of the meeting. For more information, visit http://www.hhs.gov/ash/carb/.

FOR FURTHER INFORMATION CONTACT: Jomana Musmar, Acting Designated 
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, Room 715H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 690-5566; email: [email protected].

SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 
18, 2014, authority was given to the Secretary of HHS to establish the 
Advisory Council, in consultation with the Secretaries of Defense and 
Agriculture. Activities of the Advisory Council are governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets 
forth standards for the formation and use of federal advisory 
committees.
    The Advisory Council will provide advice, information, and 
recommendations to the Secretary of HHS regarding programs and policies 
intended to support and evaluate the implementation of Executive Order 
13676, including the National Strategy for Combating Antibiotic-
Resistant Bacteria and the National Action Plan for Combating 
Antibiotic-Resistant Bacteria. The Advisory Council shall function 
solely for advisory purposes.
    In carrying out its mission, the Advisory Council will provide 
advice, information, and recommendations to the Secretary regarding 
programs and policies intended to preserve the effectiveness of 
antibiotics by optimizing their use; advance research to develop 
improved methods for combating antibiotic resistance and conducting 
antibiotic stewardship; strengthen surveillance of antibiotic-resistant 
bacterial infections; prevent the transmission of antibiotic-resistant 
bacterial infections; advance the development of rapid point-of-care 
and agricultural diagnostics; further research

[[Page 38913]]

on new treatments for bacterial infections; develop alternatives to 
antibiotics for agricultural purposes; maximize the dissemination of 
up-to-date information on the appropriate and proper use of antibiotics 
to the general public and human and animal healthcare providers; and 
improve international coordination of efforts to combat antibiotic 
resistance.
    The first day of the public meeting, September 13, 2017, will be 
dedicated to the topic of Stewardship of Antibiotic Prescription and 
Use. The three working groups on Incentives for Diagnostics, 
Therapeutics/Anti-Infectives, and Vaccines, will report their final 
findings to the full Advisory Council for deliberation on the second 
day of the public meeting, September 14, 2017, and the Advisory Council 
will deliberate and vote on the final report presented. Additionally, 
federal agencies will provide updates on their achievements as 
stipulated in the goals with corresponding objectives and milestones of 
the National Action Plan on Combating Antibiotic Resistant Bacteria. 
The meeting agenda will be posted on the Advisory Council Web site at 
http://www.hhs.gov/ash/carb/ when it has been finalized. All agenda 
items are tentative and subject to change.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Advisory Council at the address/telephone number listed 
above at least one week prior to the meeting. For those unable to 
attend in person, a live webcast will be available. More information on 
registration and accessing the webcast can be found at http://www.hhs.gov/ash/carb/.
    Members of the public will have the opportunity to provide comments 
prior to the Advisory Council meeting by emailing [email protected]. Public 
comments should be sent in by midnight September 5, 2017, and should be 
limited to no more than one page. All public comments received prior to 
September 5, 2017, will be provided to Advisory Council members; 
comments are limited to two minutes per speaker.

    Dated: August 2, 2017.
Jomana F. Musmar,
Acting Designated Federal Officer, Presidential Advisory Council on 
Combating Antibiotic-Resistant Bacteria, Committee Manager.
[FR Doc. 2017-17322 Filed 8-15-17; 8:45 am]
 BILLING CODE 4150-44-P